Correlation Between Estrella Immunopharma and Pernod Ricard

Can any of the company-specific risk be diversified away by investing in both Estrella Immunopharma and Pernod Ricard at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Estrella Immunopharma and Pernod Ricard into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Estrella Immunopharma and Pernod Ricard SA, you can compare the effects of market volatilities on Estrella Immunopharma and Pernod Ricard and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Estrella Immunopharma with a short position of Pernod Ricard. Check out your portfolio center. Please also check ongoing floating volatility patterns of Estrella Immunopharma and Pernod Ricard.

Diversification Opportunities for Estrella Immunopharma and Pernod Ricard

-0.49

Correlation Coefficient

Estrella Immunopharma  Pernod Ricard

Very good diversification

The 3 months correlation between Estrella and Pernod is -0.49. Overlapping area represents the amount of risk that can be diversified away by holding Estrella Immunopharma and Pernod Ricard SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pernod Ricard SA and Estrella Immunopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Estrella Immunopharma are associated (or correlated) with Pernod Ricard. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pernod Ricard SA has no effect on the direction of Estrella Immunopharma i.e., Estrella Immunopharma and Pernod Ricard go up and down completely randomly.

Pair Corralation between Estrella Immunopharma and Pernod Ricard

Assuming the 90 days horizon Estrella Immunopharma is expected to generate 20.78 times more return on investment than Pernod Ricard. However, Estrella Immunopharma is 20.78 times more volatile than Pernod Ricard SA. It trades about 0.15 of its potential returns per unit of risk. Pernod Ricard SA is currently generating about -0.16 per unit of risk. If you would invest  9.00  in Estrella Immunopharma on September 4, 2024 and sell it today you would earn a total of  0.10  from holding Estrella Immunopharma or generate 1.11% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	31.25%
Values	Daily Returns

Estrella Immunopharma  vs.  Pernod Ricard SA

Estrella Immunopharma

Risk-Adjusted Performance

0 of 100

Good

Over the last 90 days Estrella Immunopharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly weak basic indicators, Estrella Immunopharma showed solid returns over the last few months and may actually be approaching a breakup point.

Pernod Ricard SA

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Pernod Ricard SA has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's fundamental indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Estrella Immunopharma and Pernod Ricard

The main advantage of trading using opposite Estrella Immunopharma and Pernod Ricard positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Estrella Immunopharma position performs unexpectedly, Pernod Ricard can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pernod Ricard will offset losses from the drop in Pernod Ricard's long position.

The idea behind Estrella Immunopharma and Pernod Ricard SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.